Expression of DDX3 is directly modulated by hypoxia inducible factor-1 alpha in breast epithelial cells

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Botlagunta, Mahendran ^a   Krishnamachary, Balaji ^a   Vesuna, Farhad ^a   Winnard Jr , Paul T ^a   Bol, Guus M ^a   Patel, Arvind H ^b   Raman, Venu ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DEAD BOX PROTEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; LUCIFERASE; ONCOPROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR DDX3; UNCLASSIFIED DRUG; COBALT; COBALT CHLORIDE; DDX3X PROTEIN, HUMAN;

ARTICLE; BINDING SITE; BREAST CANCER; BREAST EPITHELIUM; CANCER CELL CULTURE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DDX3 GENE; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PROMOTER REGION; PROTEIN BINDING; REPORTER GENE; RNA TRANSLATION; TRANSACTIVATION; TUMOR XENOGRAFT; UPREGULATION; ANIMAL; BREAST; CELL HYPOXIA; DNA RESPONSIVE ELEMENT; DRUG EFFECT; DRUG SCREENING; EPITHELIUM CELL; FEMALE; GENETICS; METABOLISM; MOLECULAR GENETICS; MOUSE; NUCLEOTIDE SEQUENCE; PATHOLOGY; PROTEIN STABILITY; PROTEIN TRANSPORT; TUMOR CELL LINE;

ANIMALS; BASE SEQUENCE; BREAST; CELL HYPOXIA; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; COBALT; DEAD-BOX RNA HELICASES; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICE; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN STABILITY; PROTEIN TRANSPORT; RESPONSE ELEMENTS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79952912527     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017563     Document Type: Article

References (52)

1. Lahn BT, Page DC, (1997) Functional coherence of the human Y chromosome. Science 278: 675-680.
2. Cordin O, Banroques J, Tanner NK, Linder P, (2006) The DEAD-box protein family of RNA helicases. Gene 367: 17-37.
3. Linder P, (2006) Dead-box proteins: a family affair-active and passive players in RNP-remodeling. Nucleic Acids Res 34: 4168-4180.
4. Rocak S, Linder P, (2004) DEAD-box proteins: the driving forces behind RNA metabolism. Nat Rev Mol Cell Biol 5: 232-241.
5. Leroy P, Alzari P, Sassoon D, Wolgemuth D, Fellous M, (1989) The protein encoded by a murine male germ cell-specific transcript is a putative ATP-dependent RNA helicase. Cell 57: 549-559.
6. Johnstone O, Deuring R, Bock R, Linder P, Fuller MT, et al. (2005) Belle is a Drosophila DEAD-box protein required for viability and in the germ line. Dev Biol 277: 92-101.
7. Jamieson DJ, Beggs JD, (1991) A suppressor of yeast spp81/ded1 mutations encodes a very similar putative ATP-dependent RNA helicase. Mol Microbiol 5: 805-812.
8. Gururajan R, Perry-O'Keefe H, Melton DA, Weeks DL, (1991) The Xenopus localized messenger RNA An3 may encode an ATP-dependent RNA helicase. Nature 349: 717-719.
9. Matzuk MM, Lamb DJ, (2002) Genetic dissection of mammalian fertility pathways. Nat Cell Biol 4 (Suppl): s41-49.
10. Yedavalli VS, Neuveut C, Chi YH, Kleiman L, Jeang KT, (2004) Requirement of DDX3 DEAD box RNA helicase for HIV-1 Rev-RRE export function. Cell 119: 381-392.
11. Schroder M, Baran M, Bowie AG, (2008) Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKepsilon-mediated IRF activation. The EMBO journal 27: 2147-2157.
12. Owsianka AM, Patel AH, (1999) Hepatitis C virus core protein interacts with a human DEAD box protein DDX3. Virology 257: 330-340.
13. Noueiry AO, Chen J, Ahlquist P, (2000) A mutant allele of essential, general translation initiation factor DED1 selectively inhibits translation of a viral mRNA. Proc Natl Acad Sci U S A 97: 12985-12990.
14. Mamiya N, Worman HJ, (1999) Hepatitis C virus core protein binds to a DEAD box RNA helicase. J Biol Chem 274: 15751-15756.
15. Ariumi Y, Kuroki M, Abe K, Dansako H, Ikeda M, et al. (2007) DDX3 DEAD-box RNA helicase is required for hepatitis C virus RNA replication. J Virol 81: 13922-13926.
16. Angus AG, Dalrymple D, Boulant S, McGivern DR, Clayton RF, et al. (2010) Requirement of cellular DDX3 for hepatitis C virus replication is unrelated to its interaction with the viral core protein. The Journal of general virology 91: 122-132.
17. Schroder M, (2010) Human DEAD-box protein 3 has multiple functions in gene regulation and cell cycle control and is a prime target for viral manipulation. Biochem Pharmacol 79: 297-306.
18. Chao CH, Chen CM, Cheng PL, Shih JW, Tsou AP, et al. (2006) DDX3, a DEAD box RNA helicase with tumor growth-suppressive property and transcriptional regulation activity of the p21waf1/cip1 promoter, is a candidate tumor suppressor. Cancer Res 66: 6579-6588.
19. Botlagunta M, Vesuna F, Mironchik Y, Raman A, Lisok A, et al. (2008) Oncogenic role of DDX3 in breast cancer biogenesis. Oncogene 27: 3912-3922.
20. Hirohashi S, (1998) Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol 153: 333-339.
21. Baranwal S, Alahari SK, (2009) Molecular mechanisms controlling E-cadherin expression in breast cancer. Biochem Biophys Res Commun 384: 6-11.
22. Vesuna F, van Diest P, Chen JH, Raman V, (2008) Twist is a transcriptional repressor of E-cadherin gene expression in breast cancer. Biochem Biophys Res Commun 367: 235-241.
23. Sun M, Song L, Li Y, Zhou T, Jope RS, (2008) Identification of an antiapoptotic protein complex at death receptors. Cell Death Differ 15: 1887-1900.
24. Vaupel P, (2004) Tumor microenvironmental physiology and its implications for radiation oncology. Semin Radiat Oncol 14: 198-206.
25. Polyak K, Haviv I, Campbell IG, (2009) Co-evolution of tumor cells and their microenvironment. Trends in genetics: TIG 25: 30-38.
26. Lahiri S, Roy A, Baby SM, Hoshi T, Semenza GL, et al. (2006) Oxygen sensing in the body. Prog Biophys Mol Biol 91: 249-286.
27. Hu M, Polyak K, (2008) Microenvironmental regulation of cancer development. Curr Opin Genet Dev 18: 27-34.
28. Hockel M, Vaupel P, (2001) Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 93: 266-276.
29. Dougherty GJ, Dougherty ST, (2009) Exploiting the tumor microenvironment in the development of targeted cancer gene therapy. Cancer Gene Ther 16: 279-290.
30. Wenger RH, Gassmann M, (1997) Oxygen(es) and the hypoxia-inducible factor-1. Biol Chem 378: 609-616.
31. Tian H, McKnight SL, Russell DW, (1997) Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev 11: 72-82.
32. Semenza GL, (2000) HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol 88: 1474-1480.
33. Semenza GL, (1999) Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 15: 551-578.
34. Gu YZ, Moran SM, Hogenesch JB, Wartman L, Bradfield CA, (1998) Molecular characterization and chromosomal localization of a third alpha-class hypoxia inducible factor subunit, HIF3alpha. Gene Expr 7: 205-213.
35. Wiesener MS, Jurgensen JS, Rosenberger C, Scholze CK, Horstrup JH, et al. (2003) Widespread hypoxia-inducible expression of HIF-2alpha in distinct cell populations of different organs. The FASEB journal: official publication of the Federation of American Societies for Experimental Biology 17: 271-273.
36. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, et al. (1999) The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399: 271-275.
37. Kallio PJ, Okamoto K, O'Brien S, Carrero P, Makino Y, et al. (1998) Signal transduction in hypoxic cells: inducible nuclear translocation and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-1alpha. The EMBO journal 17: 6573-6586.
38. Ema M, Hirota K, Mimura J, Abe H, Yodoi J, et al. (1999) Molecular mechanisms of transcription activation by HLF and HIF1alpha in response to hypoxia: their stabilization and redox signal-induced interaction with CBP/p300. The EMBO journal 18: 1905-1914.
39. Wenger RH, Stiehl DP, Camenisch G, (2005) Integration of oxygen signaling at the consensus HRE. Sci STKE 2005: re12.
40. Vaupel P, Thews O, Hoeckel M, (2001) Treatment resistance of solid tumors: role of hypoxia and anemia. Med Oncol 18: 243-259.
41. Knowles HJ, Harris AL, (2001) Hypoxia and oxidative stress in breast cancer. Hypoxia and tumourigenesis. Breast Cancer Res 3: 318-322.
42. Bracken CP, Whitelaw ML, Peet DJ, (2005) Activity of hypoxia-inducible factor 2alpha is regulated by association with the NF-kappaB essential modulator. The Journal of biological chemistry 280: 14240-14251.
43. Blancher C, Moore JW, Talks KL, Houlbrook S, Harris AL, (2000) Relationship of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression to vascular endothelial growth factor induction and hypoxia survival in human breast cancer cell lines. Cancer Res 60: 7106-7113.
44. Teicher BA, Dupuis NP, Robinson MF, Kusumoto T, Liu M, et al. (1994) Reduced oxygenation in a rat mammary carcinoma post-radiation and reoxygenation with a perflubron emulsion/carbogen breathing. In Vivo 8: 125-131.
45. Reynolds TY, Rockwell S, Glazer PM, (1996) Genetic instability induced by the tumor microenvironment. Cancer Res 56: 5754-5757.
46. Brizel DM, Scully SP, Harrelson JM, Layfield LJ, Bean JM, et al. (1996) Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res 56: 941-943.
47. Niquet J, Seo DW, Allen SG, Wasterlain CG, (2006) Hypoxia in presence of blockers of excitotoxicity induces a caspase-dependent neuronal necrosis. Neuroscience 141: 77-86.
48. Guo X, Philipsen S, Tan-Un KC, (2007) Study of the hypoxia-dependent regulation of human CYGB gene. Biochem Biophys Res Commun 364: 145-150.
49. Warnecke C, Zaborowska Z, Kurreck J, Erdmann VA, Frei U, et al. (2004) Differentiating the functional role of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha (EPAS-1) by the use of RNA interference: erythropoietin is a HIF-2alpha target gene in Hep3B and Kelly cells. The FASEB journal: official publication of the Federation of American Societies for Experimental Biology 18: 1462-1464.
50. Sowter HM, Raval RR, Moore JW, Ratcliffe PJ, Harris AL, (2003) Predominant role of hypoxia-inducible transcription factor (Hif)-1alpha versus Hif-2alpha in regulation of the transcriptional response to hypoxia. Cancer Res 63: 6130-6134.
51. Sekiguchi T, Iida H, Fukumura J, Nishimoto T, (2004) Human DDX3Y, the Y-encoded isoform of RNA helicase DDX3, rescues a hamster temperature-sensitive ET24 mutant cell line with a DDX3X mutation. Exp Cell Res 300: 213-222.
52. Han ZB, Ren H, Zhao H, Chi Y, Chen K, et al. (2008) Hypoxia-inducible factor (HIF)-1 alpha directly enhances the transcriptional activity of stem cell factor (SCF) in response to hypoxia and epidermal growth factor (EGF). Carcinogenesis 29: 1853-1861.